Ingelheim, Germany, Friday, 24/10/2025 – 08 :00 CET Boehringer Ingelheim today announced new data from …
Tag:
Boehringer Ingelheim
-
-
Lifestyle & Healthslider
Over 300 Experts Gather at Boehringer Ingelheim’ s CRM Summit to Explore Advances in Cardio-Renal-Metabolic Care
by Karine Ayoubby Karine AyoubAbu Dhabi, United Arab Emirates, 20/10/2025 Boehringer Ingelheim, one of the world’s leading research-driven …
-
Lifestyle & Healthslider
Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches
by Karine Ayoubby Karine AyoubNumber of patients reached in 2024 jumps 8% to 66 million. In 2024, Boehringer …
-
Lifestyle & Healthslider
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
by Karine Ayoubby Karine AyoubIngelheim, Germany, 13/03/2025 Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met …
-
Lifestyle & Healthslider
Boehringer Ingelheim Launches Fast-acting Stroke Medication in the UAE, Reducing Treatment Administration to Five Seconds
by Karine Ayoubby Karine AyoubThe newly approved treatment provides a fast-acting option for acute ischemic stroke (AIS) care. …
-
Lifestyle & Healthslider
Dubai Miracle Garden Blooms with Hope as Boehringer Ingelheim Concludes Interstitial Lung Disease Awareness Campaign
by Karine Ayoubby Karine AyoubInterstitial Lung Disease (ILD) is an umbrella term used for a large group of …
-
Lifestyle & Healthslider
Boehringer Ingelheim Launches Broadest Spectrum Parasiticide for Cats in the UAE
by Karine Ayoubby Karine AyoubThe solution combines three medications delivering the broadest spectrum of protection against internal and …
-
Lifestyle & Healthslider
Boehringer’s nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
by Karine Ayoubby Karine AyoubIngelheim, Germany, Mon, 16/09/2024 – 12:00 Boehringer Ingelheim announced today that the FIBRONEER™-IPF trial …
-
Lifestyle & Healthslider
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
by Karine Ayoubby Karine AyoubR&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales) …
-
Lifestyle & Healthslider
Boehringer Ingelheim Breaks Guinness World Records™ title In Solidarity with Rare Disease Patients Around the World
by Karine Ayoubby Karine AyoubTo mark the Rare Disease Awareness Month, Boehringer Ingelheim created the Largest Video Chain …
Newer Posts